The following is a round-up of updates by London-listed companies, issued on Wednesday, Thursday and Friday and not separately reported by Alliance News:
----------
BWA Group PLC - London-based company which has mineral exploration licences in Cameroon and Canada - Proposes to raise up to £900,000 via a placement of 180.0 million new shares at 0.5 pence per share. Says the majority of funds raised will be used to continue its exploration programme on its two claim areas in Cameroon at Nkoteng and Dehane for Heavy Mineral Sands.
----------
Augmentum Fintech PLC - London-headquartered investor focused on European private fintech companies - Invests further £4.2 million in business banking platform, Tide, through primary and secondary transactions.
----------
PanGenomic Health Inc - Vancouver, Canada-based precision health company - Intends to close share for a $281,965 debt settlement through the issue of 2.1 million units in its capital and 3.5 million common shares, at a deemed price of $0.05 per share.
----------
Dunedin Income Growth Investment Trust PLC - Edinburgh-based UK and overseas companies’ investor - Inks deal for Dunedin Buyout Fund II LP’s investment in manufacturer and supplier of engineered metals solutions, Premier Hytemp Ltd. Says completion of the transaction is subject to satisfaction of certain customary closing conditions. Proceeds from the sale are expected to amount to £4.9m, consisting entirely of capital. Dunedin Buyout Fund II is an Edinburgh-based buyout fund managed by Dunedin.
----------
Gama Aviation PLC - Farnborough, England-based aviation services company - Says 100% of voting shareholders approve the sale of Gama Group Inc to West Star Aviation Enterprises, LLC.
----------
Alternative Income REIT PLC - London-based investor, which specialises in alternative and specialist real estate sectors such as hotels and healthcare - Says net asset value at September 30 fell 0.7% to 83.6 pence per share from 84.2p at June 30, while NAV total return was 1.6%, down from 2.4% in the previous quarter. Declares an interim dividend of 1.425p per share and targets a 5.9p dividend for the year ending September 30, 2024, up 3.5% from 5.7p a year ago.
----------
Syncona Ltd - London-based investor in healthcare companies - Notes portfolio company Autolus Therapeutics third quarter pretax loss widened in the third quarter ended September 30 to $50.8 million from $48.9 million a year prior. Says Autolus’ third quarter operating expenses grew 9.9% to $47.8million from $43.5 million.
----------
Copyright 2023 Alliance News Ltd. All Rights Reserved.
